Design of Original Bioactive Formulations Based on Sugar–Surfactant/Non-steroidal Anti-inflammatory Catanionic Self-Assemblies: A New Way of Dermal Drug Delivery-Reference-Cited by-同舟云学术

Design of Original Bioactive Formulations Based on Sugar–Surfactant/Non-steroidal Anti-inflammatory Catanionic Self-Assemblies: A New Way of Dermal Drug Delivery

Published:2007-04-05 Issue:11 Volume:13 Page:3039-3047
ISSN:0947-6539
Container-title:Chemistry - A European Journal
language:en
Short-container-title:Chem. Eur. J.

Author:

Consola Sabrina,Blanzat Muriel,Perez Emile,Garrigues Jean-Christophe,Bordat Pascal,Rico-Lattes Isabelle

Publisher

Wiley

Subject

General Chemistry,Catalysis,Organic Chemistry

Reference39 articles.

1. Pharmacokinetic and local tissue disposition studies of naproxen following topical and systemic administration in dogs and rats

2. Transdermal drug delivery: overcoming the skin’s barrier function

3. Passive skin penetration enhancement and its quantification in vitro

4. The selection of non-steroidal anti-inflammatory agents for dermal delivery

5. A Comparative Study of the Transdermal Penetration of a Series of Nonsteroidal Antiinflammatory Drugs

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review on novel targeted enzyme drug delivery systems: enzymosomes;Soft Matter;2024

2. Model Catanionic Vesicles from Biomimetic Serine-Based Surfactants: Effect of the Combination of Chain Lengths on Vesicle Properties and Vesicle-to-Micelle Transition;Membranes;2023-02-01

3. Synthesis, physicochemical characterization and aquatic toxicity studies of anionic surfactants derived from amino and α-hydroxy acids;RSC Sustainability;2023

4. Physical-chemical and toxicological properties of osmolyte-based cationic surfactants and spontaneously formed low-toxic catanionic vesicles out of them;Journal of Molecular Liquids;2022-09

5. Amphiphilic Ionic Liquids Capable to Formulate Organized Systems in an Aqueous Solution, Designed by a Combination of Traditional Surfactants and Commercial Drugs;Pharmaceutical Research;2022-07-19